secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001193125-23-175223
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 1.01, 3.03, 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences extends rights agreement expiration to July 2024; sets 2023 annual meeting for September 19
--------------------------------------------------------------------------------

- Amendment No. 1 extends Rights Agreement expiration to 5:00 p.m. ET on July 12, 2024, unless earlier redeemed or exchanged.
- 2023 Annual Meeting of Stockholders scheduled for September 19, 2023.
- Stockholder proposals for proxy inclusion or director nominations must be received by July 6, 2023.
- All other terms of the Rights Agreement remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523175223/0001193125-23-175223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523175223/d444385d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-175223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer